Tissue engineering involves developing biological substitutes that restore, maintain, or improve damaged tissue functions. It uses a combination of cells, engineering, materials techniques, and suitable biochemical and physicochemical factors to help the regeneration of functional tissues. It has applications across various medical disciplines like orthopedics, neurology, cardiology, and wound care. Owing to the increasing prevalence of chronic and lifestyle-related diseases, there is a growing demand for tissue-engineered products for wound healing.

The Tissue Engineering market is estimated to be valued at US$ 10570.17 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:
The growth of the tissue engineering market is majorly driven by the rising prevalence of chronic diseases and trauma injuries. Chronic diseases like cardiovascular diseases, diabetes, obesity are increasing due to changing lifestyles. Moreover, increasing road accidents and trauma cases are also fueling the demand for tissue-engineered products in wound care and healing applications. According to the estimates of World Health Organization (WHO), cardiovascular diseases (CVDs) are the number one cause of death globally, taking an estimated 17.9 million lives each year. Therefore, the increasing burden of chronic and lifestyle-related diseases is expected to propel the tissue engineering market growth during the forecast period. Additionally, advancements in regenerative medicine, increasing R&D in tissue engineering techniques, and growing application areas are also contributing to the market growth.

Explorer more information on this topic, Please visit @ https://makuv.com/3d-bioprinting-is-fastest-growing-segment-fueling-the-growth-of-tissue-engineering-market